These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Selectivity of [125I]-PD151242 for human, rat and porcine endothelin ETA receptors in the heart. Peter MG, Davenport AP. Br J Pharmacol; 1995 Jan; 114(2):297-302. PubMed ID: 7881728 [Abstract] [Full Text] [Related]
6. Characterization of [125I]-PD164333, an ETA selective non-peptide radiolabelled antagonist, in normal and diseased human tissues. Davenport AP, Kuc RE, Ashby MJ, Patt WC, Doherty AM. Br J Pharmacol; 1998 Jan; 123(2):223-30. PubMed ID: 9489609 [Abstract] [Full Text] [Related]
11. Characterization of the binding of endothelin ETB selective ligands in human and rat heart. Russell FD, Davenport AP. Br J Pharmacol; 1996 Oct; 119(4):631-6. PubMed ID: 8904635 [Abstract] [Full Text] [Related]
12. Endothelin-1 binding to endothelin receptors in the rat anterior pituitary gland: possible formation of an ETA-ETB receptor heterodimer. Harada N, Himeno A, Shigematsu K, Sumikawa K, Niwa M. Cell Mol Neurobiol; 2002 Apr; 22(2):207-26. PubMed ID: 12363203 [Abstract] [Full Text] [Related]
13. Characterization of the endothelin receptor selective agonist, BQ3020 and antagonists BQ123, FR139317, BQ788, 50235, Ro462005 and bosentan in the heart. Peter MG, Davenport AP. Br J Pharmacol; 1996 Feb; 117(3):455-462. PubMed ID: 8821534 [Abstract] [Full Text] [Related]
14. Characterization of [125I]-endothelin-1 and [125I]-BQ3020 binding to rat cerebellar endothelin receptors. Widdowson PS, Kirk CN. Br J Pharmacol; 1996 Aug; 118(8):2126-30. PubMed ID: 8864551 [Abstract] [Full Text] [Related]
15. Characterization of two new ETB selective radioligands, [125I]-BQ3020 and [125I]-[Ala1,3,11,15]ET-1 in human heart. Molenaar P, Kuc RE, Davenport AP. Br J Pharmacol; 1992 Nov; 107(3):637-9. PubMed ID: 1472961 [Abstract] [Full Text] [Related]
16. Pharmacological characterization of the rat cerebellar endothelin B (ETB) receptor using the novel agonist radioligand [125I]BQ3020. Jarvis MF, Assal AA, Gessner G. Brain Res; 1994 Nov 28; 665(1):33-8. PubMed ID: 7882015 [Abstract] [Full Text] [Related]
17. High affinity interaction of endothelin-3 with recombinant ETA receptors. Desmarets J, Frelin C. Biochem Biophys Res Commun; 1999 Mar 16; 256(2):357-60. PubMed ID: 10079188 [Abstract] [Full Text] [Related]
18. [3H]BQ-123, a highly specific and reversible radioligand for the endothelin ETA receptor subtype. Ihara M, Yamanaka R, Ohwaki K, Ozaki S, Fukami T, Ishikawa K, Towers P, Yano M. Eur J Pharmacol; 1995 Feb 14; 274(1-3):1-6. PubMed ID: 7768260 [Abstract] [Full Text] [Related]
19. Novel ligands BQ123 and BQ3020 characterize endothelin receptor subtypes ETA and ETB in human kidney. Karet FE, Kuc RE, Davenport AP. Kidney Int; 1993 Jul 14; 44(1):36-42. PubMed ID: 8355464 [Abstract] [Full Text] [Related]
20. Characterization of peptide and nonpeptide antagonists in human kidney. Kuc RE, Karet FE, Davenport AP. J Cardiovasc Pharmacol; 1995 Jul 14; 26 Suppl 3():S373-5. PubMed ID: 8587419 [Abstract] [Full Text] [Related] Page: [Next] [New Search]